Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

A recent study has found that a drug commonly used to treat high blood pressure may be linked to an increased risk of sudden ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Losing weight can support better heart health, but now doctors are warning of their possible impacts on your heart. Ozempic, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

This charming old-school diner isn’t just a place to grab a quick bite; it’s a portal to a bygone era where soda jerks ruled ...

Valentine’s Day represents a perfect opportunity to highlight news and updates from across biopharma that have hearts a | ...